Mark S. Rouse

62 papers receiving 2.6k citations

Peers

Mark S. Rouse
Comparison fields: 5 of 120
  • Clinical Biochemistry 433
  • Molecular Medicine 283
  • Infectious Diseases 940
  • Applied Microbiology and Biotechnology 50
  • Epidemiology 835
Replace Kerryl E. Piper with:
Kerryl E. Piper United States
James S. Tan United States
Joan Gavaldà Spain
F. Espersen Denmark
Cédric Jacqueline France
W. Zimmerli Switzerland
Elisabeth Presterl Austria
E. Nagy Hungary
Iain B. Gosbell Australia
Jari Jalava Finland
Mark S. Rouse relative to Kerryl E. Piper United States Kerryl E. Piper's profile →
Citations per field
00.5×1.5×
Kerryl E. Piper · 1×
Citations per year

Countries citing papers authored by Mark S. Rouse

Since Specialization
Citations

This map shows the geographic impact of Mark S. Rouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Rouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Rouse more than expected).

Fields of papers citing papers by Mark S. Rouse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Rouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Rouse. The network helps show where Mark S. Rouse may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark S. Rouse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark S. Rouse Line = papers co-authored together Mark S. Rouse links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1990173
2 2000149
3 2008128
4 1999124
5 2008120
6 2000101
7 200898
8 199894
9
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
198789
10 200288
11 200382
12 201081
13 200680
14 200980
15 200573
16 200669
17 200965
18 200460
19 200056
20 199650

About Mark S. Rouse

Mark S. Rouse is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Clinical Biochemistry and Surgery, having authored 62 papers that have together received 2.7k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (30 papers), Infective Endocarditis Diagnosis and Management (18 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Bacterial Identification and Susceptibility Testing (14 papers), Orthopedic Infections and Treatments (13 papers), Streptococcal Infections and Treatments (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Bacterial biofilms and quorum sensing (6 papers). The work is most often cited by research in Clinical Biochemistry (433 citations), Molecular Medicine (283 citations), Infectious Diseases (940 citations), Applied Microbiology and Biotechnology (50 citations) and Epidemiology (835 citations). Mark S. Rouse has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include Robin Patel, James M. Steckelberg, Kerryl E. Piper, José Luís del Pozo, Jayawant N. Mandrekar, Walter R. Wilson, Arlen D. Hanssen, Nancy K. Henry, Franklin R. Cockerill and Duane M. Ilstrup. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Diagnostic Microbiology and Infectious Disease, Clinical Orthopaedics and Related Research, Journal of Clinical Microbiology and Journal of Antimicrobial Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact